- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04516473
The Impact of Abdominal Body Contouring Surgery on Physical Function After a Massive Weight Loss (BCSP) (BCSP)
The Impact of Abdominal Body Contouring Surgery on Physical Function After a Massive Weight Loss: a Non-randomized Control Trial
Obesity is a growing chronic medical condition in which as of 2015, a total of 107.7 million children and 603.7 million adults were considered obese and since 1980 the prevalence of obesity has doubled in more than 70 countries. It is estimated that 70 percent of individuals who undergo a massive weight loss would develop excess skin and based on patient reported outcome measures, it has been shown that excess skin negatively impacts patients' body image, self-esteem, physical function and body contouring surgeries have been demonstrated to improve these measures. These are surgeries that correct for excess skin and its adverse consequences. The form of the surgery is case dependent and can range from removing an apron of skin to complete contouring of the abdomen with tightening of the abdominal muscle and moving the belly button. Despite previous studies indicating mobility limitation because of excess skin and improvements after abdominal body contouring surgeries with the use of subjective measures of physical function, there are no studies that directly measures physical fitness post body contouring surgeries. Therefore, the purpose of the current study is to evaluate the impact of abdominal body contouring surgeries on direct objective measures of physical function.
It is hypothesized that 1) the removal of excess skin will improve direct objective measures of physical function in post massive weight loss participants 2) the removal of excess skin will improve direct measures of gait and balance in post massive weight loss participants 3) the removal of excess skin will improve patient reported outcome measures using quality of life questionnaires in post massive weight loss participants 4) the removal of excess skin will improve aerobic capacity in post massive weight loss participants 5) the removal of excess skin does not change the body composition in post massive weight loss participants.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be recruited through multiple medical clinics and will visit the exercise, nutrition and muscle metabolism lab twice over the course of 8-12 weeks to complete objective and subjective measures of physical function. Each testing session will be conducted by the study investigator and physical function testing will be video recorded to reduce measurer bias. Based on participants' status they will be allocated to either a body contouring intervention group (BCI) or a post massive weight loss matched control (PMWMC). The first testing session would happen preoperatively and second one would happen between 8-12 weeks postoperatively depending on recovery required. Pain levels will be measured both pre and postoperatively using a numerical rating scale (0-10) to ensure adequate recovery.
Outcomes will include a variety of objective measures of physical function including 9-item modified physical performance test (mPPT), 30 second chair stand, timed up and go, stair climbing power, modified agility t-test, star excursion balance test, and 6 minute walk test. A body composition measure consisting of fat mass and fat free mass will also be obtained via dual-energy X-ray absorptiometry. Subjective measures would include 6 components of health related quality of life measure using BODY-Q questionnaire that would include sub scales such as body image, physical function, psychological, sexual, social, and obesity symptoms. Other subjective measure would include rate of perceived exertion which would be measured during each of the objective tests.
Additionally, grade of excess skin would be measured by images provided to the participants and weight of the resected excess skin will be obtained from the operating surgeon at the end of the study.
To obtain demographic history, physical activity level post surgery and to gain feedback for future clinical trial, the participants will also complete a socioeconomic status questionnaire, physical activity questionnaire, and participant experience with research questionnaire.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6T 1Z3
- University of British Columbia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Male and female who have undergone a massive weight loss through any weight loss intervention, have excess skin, are healthy enough to perform simple physical function tasks and self-selected to undergo abdominal skin removal surgery.
Participants who have similar criteria to the intervention group but will not undergo surgical intervention during the course of the study will serve as a control group.
Description
Inclusion Criteria:
- Weight has not deviated by greater than 5 percent for 3 months
- Have excess grade skin of greater or equal to 2
- Percent total weight loss pre-body contouring of greater or equal to 25 percent
- Fluently read and write English
Exclusion Criteria:
- Any musculoskeletal issues that would prevent participants from doing the physical function tests.
- Current medication history indicating atypical antipsychotics including but not limited to clozapine, olanzapine, quetiapine, risperidone, aripiprazole, amisulpride, ziprasidone, asenapine, iloperidone, lurasidone and paliperidone.
- Severe pulmonary conditions such as severe chronic obstructive pulmonary disease (COPD) and or severe asthma.
- Participants who actively aiming to lose weight
- Have diabetes with diabetic neuropathy or experienced hypoglycemic event within 6 months prior to the study
- Severe kidney disease with estimated glomerular filtration rate (eGFR) less than 60 ml/min
- Pregnant individuals
- Uncontrolled hypertension with resting blood pressure greater than 160/90 mmHg
- Uncontrolled obstructive sleep apnea with symptoms
- On statin therapy with myopathy
- Unstable atrial fibrillation
- Weight pre-body contouring greater than 340 lbs (154 kg)
- Current smoker
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Experimental/Body Contouring Intervention
These are participants who have self-selected to undergo an abdominal body contouring procedure within the course of the study.
|
These are surgeries that correct for excess skin and its adverse consequences.
The surgeries that focus on central area to remove a large hanging pannus is usually called panniculectomies or abdominoplasties; the former is focused on the excision of excess tissue to relieve impairment while the latter is generally considered a cosmetic surgery.
The form of the surgery is case dependent and can range from removing apron of skin to complete contouring of the abdomen with tightening of the abdominal muscle and moving the belly button.
|
Control/Post Massive Weight Loss Matched Control
These are participants who have similar characteristics to the body contouring intervention group, but they will not undergo any surgical procedure during the course of the study. The addition of this matched control group with a similar degree of excess skin but who will not be undergoing body contouring surgery will control for any changes in physical function which may occur without any intervention within the testing sessions. This group will also control for any learning effects between testing sessions. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical function aggregate score
Time Frame: 8-12 weeks
|
Measured by 9-item modified physical performance test that gives an aggregate score out 36 and comprises of 9 tests pre and post surgery and includes the following:
Lowest score is 0, highest score is 36 and higher scores represent better outcomes. |
8-12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in lower body strength
Time Frame: 8-12 weeks
|
Measured by number of stands completed during a 30 seconds chair stand pre and post surgery
|
8-12 weeks
|
Change in time to complete agility drill
Time Frame: 8-12 weeks
|
Measured by time to complete a modified agility t-test pre and post surgery
|
8-12 weeks
|
Change in timed up and go
Time Frame: 8-12 weeks
|
Measured by time to complete a timed up and go test
|
8-12 weeks
|
Change in stair climbing power
Time Frame: 8-12 weeks
|
Measured by time to ascend 10 stairs and deriving power pre and post surgery
|
8-12 weeks
|
Change in dynamic balance balance
Time Frame: 8-12 weeks
|
Measured by star excursion balance test pre and post surgery
|
8-12 weeks
|
Change in aerobic capacity
Time Frame: 8-12 weeks
|
Measured by distance traveled during a 6 minute walk test pre and post surgery
|
8-12 weeks
|
Change in lean body mass
Time Frame: 8-12 weeks
|
Measured by change in bone free fat mass by using dual-energy X-ray absorptiometry pre and post surgery
|
8-12 weeks
|
Change in fat mass
Time Frame: 8-12 weeks
|
Measured by using dual-energy X-ray absorptiometry pre and post surgery
|
8-12 weeks
|
Change in patient reported outcome measure of physical function and quality of life
Time Frame: 8-12 weeks
|
Measured by 6 health related quality of life components of BODY-Q questionnaire pre and post surgery. Sub-scales would include body image, physical function, psychological, sexual, social, and obesity/physical symptoms. Each sub-scale will be graded individually, and the raw scores will be converted into a score from 0-100. For body image, physical function, psychological function, sexual, and social function higher scores represent a better outcome For obesity/physical symptoms, symptoms will be added so that the total number of symptoms experienced would be obtained. Minimum number of symptoms is 0 and maximum is 10. |
8-12 weeks
|
Change in rate of perceived exertion (RPE) during physical function tests
Time Frame: 8-12 weeks
|
Measured by BORG RPE scale pre and post surgery.
Minimum score is 6 and maximum is 20.
The scale is only to provide how much the participants are being exerted when given a task.
|
8-12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between degree of excess skin and change in objective physical function test scores
Time Frame: 8-12 weeks
|
Measured by linear models and correlating the degree of excess skin and change in measures of physical function scores from post to pre surgery
|
8-12 weeks
|
Correlation between the weight of resected excess skin and change in objective physical function tests
Time Frame: 8-12 weeks
|
Measured by linear models and correlating the amount of weight of the resected excess skin and change in measures of physical function scores from post to pre surgery
|
8-12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cameron Mitchell, PhD, Assistant Professor University of British Columbia
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H20-00960
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Abdominal Body Contouring
-
Assiut UniversityRecruitingBariatric Surgery CandidateEgypt
-
University Hospital, Basel, SwitzerlandCompleted
-
Odense University HospitalMcMaster University; Catharina Ziekenhuis Eindhoven; Tampere University Hospital and other collaboratorsRecruitingWeight Loss | Excess SkinDenmark
-
Medical University of ViennaCompleted
-
Helsinki University Central HospitalRecruitingAcute Abdomen | Radiocontrast NephropathyFinland
-
Recros Medica, Inc.UnknownSkin LaxityUnited States
-
Tianjin Medical University Cancer Institute and...Shanxi Province Cancer Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University and other collaboratorsRecruitingBreast Cancer | Esophageal Cancer | Lung CancerChina
-
University Hospital, Basel, SwitzerlandTerminated
-
Cairo UniversityUnknownCraniofacial Fibrous DysplasiaEgypt